Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.64 -0.14 (-0.49%)
Official Closing Price Updated: 4:10 PM EST, Dec 11, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Why Novavax Stock Fell Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated... 
Via Benzinga
Exposures COVID-19 Product Safety
Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe
While Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) are making great progress in cancer treatments, the importance of early detection in combating this disease cannot be overstated. 
Via Benzinga
Taylor Swift Boosts Travis Kelce's Popularity: Stocks That Could Benefit From The Love Story
NFL star Travis Kelce's romance with musician Taylor Swift could be a win for brand partners in terms of endorsements and deals. 
Via Benzinga
2 High-Yield Dividend Stocks to Buy in October
These two high-yield dividend stocks are too cheap to ignore. 
Via The Motley Fool
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.
The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck. 
Via Investor's Business Daily
October’s Stock Market Mojo
October kicks off the last quarter of the year, a time when companies and individuals are busy refining their financial positions and seeking rewarding investment avenues. 
Via Talk Markets
This Is What Whales Are Betting On Pfizer
Via Benzinga
Balancing Dividends and Fundamentals: The Case of NYSE:PFE.
Exploring PFIZER INC (NYSE:PFE)'s dividend characteristics. 
Via Chartmill
Pfizer's Diversity Program Faces Legal Heat, Advocacy Group Revives Discrimination Case
Advocacy group Do No Harm has made a case before the New York-based 2nd U.S. 
Via Benzinga
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock. 
Via Benzinga
Short Sellers Are Betting Against Novavax (NVAX) Stock
Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap. 
Via InvestorPlace
Exposures COVID-19
2 Magnificent Growth Stocks to Buy Right Now
These two biotech stocks could be big winners for patient investors. 
Via The Motley Fool
Sure Winners: 7 Stocks Set to Outperform in the Next Recession
Are you looking to invest in recession proof stocks? Here are seven stocks set to outperform in the next recession. 
Via InvestorPlace
Topics Economy
Exposures Economy
Is Pfizer Stock a Buy Now?
Pfizer shares have dropped 35% this year. 
Via The Motley Fool
The Latest Analyst Ratings for Pfizer
Via Benzinga
Is NYSE:PFE a Good Fit for Dividend Investing?
Is PFIZER INC (NYSE:PFE) suited for dividend investing? 
Via Chartmill
'Traylor' Effect? Pfizer, Campbell's Soup, Other Brands Are Basking In Travis Kelce-Taylor Swift Romance Rumors
EDO's data reveals that a Pfizer campaign featuring Kelce, which started on Sept. 22, experienced a 32% increase in company-related searches. 
Via Benzinga
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
The company can now join Pfizer and Moderna in launching an updated booster in the U.S. 
Via Investor's Business Daily
Exposures COVID-19 Product Safety
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S. 
Via Benzinga
Exposures COVID-19 Product Safety
AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug
AstraZeneca Plc (NASDAQ: AZN) has  
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
The Internet's most famous innovation-focused investor is excited about this company's innovative approach to editing the human genome. 
Via The Motley Fool
The 3 Top Value Stocks to Watch in Q4 2023
Embrace financial growth with top value stocks. Get comprehensive insights and make informed decisions for a prosperous investment journey. 
Via InvestorPlace
3 Massively Undervalued Dividend Stocks to Buy for High Total Returns
Smart investors should plan to buy these undervalued dividend stocks with a valuation gap for high total returns in the next 12 to 15 months. 
Via InvestorPlace
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
The stars are aligning for these pharmaceutical giants, making their stocks look ready to run higher in next year. 
Via InvestorPlace
3 Top Stocks to Buy in October and Hold Forever
Check out these three blue chip buys playing crucial roles in America's $6 trillion healthcare opportunity. 
Via The Motley Fool
Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19
Discover the remarkable journey of Nobel Prize laureates Kariko and Weissman, who transformed medicine with mRNA vaccines, and the financial impact on Moderna and Pfizer stocks. 
Via Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
Read the latest report on NanoViricides here 
Via Benzinga
3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street
Analysts like these stocks for very good reasons. 
Via The Motley Fool
Moderna's Shares Could Take Off if These 2 Things Happen
Moderna stock soared early in the pandemic. 
Via The Motley Fool
Why Pfizer and BioNTech Stocks Zoomed Higher Today
The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle. 
Via The Motley Fool
Exposures COVID-19
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.